4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-059634
President and CEO acquired 2,470 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2020-11-18 | Option exercise | +2,470 | $0.53 | $1,309 | 2,470 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mack David Henry President and CEO | 2020-11-18 | Option exercise · Stock Option (right to buy) | −2,470 | 492,867 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…